Supplemental Table S11 from Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype

Key Points

• Cytotoxic NK cells impede response to checkpoint immunotherapy in melanoma.
• Findings from CITE-seq data highlight marker genes specifically related to immune cell clusters.
• The analysis involved the clustering of immune cells to identify key markers in the immune-excluded phenotype.
• This study suggests a significant role of immune cells in melanoma treatment outcomes, pointing to potential therapeutic targets.